Resources for Entrepreneurs and Growing Companies

MCDEC LogoDownload the Program Book

MARCH 17

8:45 a.m. - Networking via Zoom Chat

9:00 a.m. - Welcome/Logistics—Judy Costello, Managing Director, BioHealth Innovation, Inc. (BHI)

9:00 a.m. – 4:00 p.m. - 1:1 Meetings with Program Officers*

9:05 a.m. - Overview:  SBIR/STTR Funding Opportunities at the NIH – Stephanie Fertig, HHS
                    Small Business Program Lead, National Institutes of Health (NIH)     (SLIDES) (VIDEO)

     Institute Insights re SBIR/STTR Funding Opportunities  

       9:20 a.m. - National Heart, Lung, and Blood Institute - Stephanie Davis, PhD - Small Business Program
                          Coordinator, NHLBI (SLIDES)

       9:35 a.m. - National Institute on Aging - Saroj Regmi, PhD - Health Science Administrator Office of Small
                          Business Research, NIA  (SLIDES)

      9:50 a.m. - National Institute on Drug Abuse - Elena Koustova, PhD, MBA—Director, Office of Translational
                         Initiatives and Program Innovations (OTIPI), NIDA, SBIR/STTR Coordinator, NIDA Office of Director

     10:05 a.m. - National Cancer Institute - Reema Railkar, PhD - Program Manager, NIH National Cancer -  (SLIDES)

                         Institute SBIR Development Center
     10:20 a.m. - National Institute of Allergy and Infectious Diseases - Natalia Kruchinin, PhD - SBIR/STTR
                          Program Coordinator, RTSP, DEA

10:35 a.m. - Q&A with all NIH speaker

10:50 a.m. - Networking via Zoom Chat
11:00 a.m. - SBIR Funding Opportunities at the National Science Foundation -Ben Schrag - Program Director, NSF  (SLIDES) (VIDEO)

11:30 am. - Military Medical SBIR/STTR Contract Opportunities - JR Myers, SBIR Project Manager, USAMRDC - (SLIDES) (VIDEO)

12:00 p.m. - Writing Your Specific Aims Page - Deepa Narayanan - Program Director and Team Lead, NIH National
                     Cancer Institute SBIR Development Center - (SLIDES) (VIDEO)

12:30 p.m. - Writing Your Phase II Commercialization Plan - Todd Haim, PhD - Chief, Office of Small Business
                     Research, NIA - (SLIDES) (VIDEO)

1:00 p.m. – Networking via Zoom Chat

1:30 p.m. - Funding Projects thru MIPS at the University of Maryland - Onur Unal, Manager, Life Sciences Projects,
                   Maryland Industrial Partnerships (MIPS), Maryland Technology Enterprise Institute (MTech) - (SLIDES) (VIDEO)

2:00 p.m. - Tips for a Winning Application - Rini Pek, Senior Analyst, BioHealth Innovation, Inc. (BHI) and Ashwin
                   Kulkarni, COO, miRecule -  (SLIDES) (VIDEO)

Until 4:00 p.m. - 1:1 Meetings with Program Officers Continue*

MARCH 18

1:1 Partnering Meetings with Program Officers Continue 9:00 a.m. - 4:00 p.m.*

9:30 a.m. - Networking via Zoom Chat

10:00 a.m. - Local Government Resources to Support Innovation—Resources to help you find space, build out yourfirst lab, incentivize potential angel investors, support your R&D and job growth, and MORE!  Lynne Stein Benzion, Director, Economic Development, Montgomery County Economic Dev. Corp.Sharon Disque, Economic Development Manager, City of Gaithersburg, MDCarla Merritt, Senior Business Development Representative, Maryland Department of CommerceModerator: Judy Costello, Managing Director, BioHealth Innovation, Inc. (BHI) (VIDEO)

11:00 a.m. - You Are Working on Non-Dilutive Funding, What's Next? —Next steps and additional resources togrow your company—informative conversation with Q&A. Ethel Rubin and John Sullivan,Entrepreneurs-in-Residence, BioHealth Innovation, Inc. and Anthony Saleh, CEO, miRecule - (SLIDES)

12:00 p.m. 1:1 Partnering Meetings with Program Officers Continue until 4:00 p.m.*

MARCH 19

9:00 a.m. - 4 p.m. - 1:1 Partnering Meetings with Program Officers Continue

nih seed logoBioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary that translates market-relevant research into commercial success by bringing together management, funding, and markets. BHI is seeking two experienced life science professionals with product development and investment experience to join the BHI team to serve as a part-time Entrepreneurs-in-Residence (EIR) at the National Institutes of Health (NIH).

These positions will report to and work closely with our lead at the NIH Small business Education and Entrepreneurial Development (SEED) Office to support academic and small business innovators in their efforts to validate the potential health impacts of promising scientific discoveries and advance them into healthcare products that improve patient care and enhance health.

Click here to download the full job description.

maryland-department-of-commerce-logo.png

BioParks 2017 is an opportunity to learn from biotech industry leaders, who share their data, experience, insights and vision. We will explore trends in life science research, funding resources, the marriage of life science and engineering and global partnership opportunities. Translating discoveries from the laboratory to the market has never been more important.

https://www.kitchology.com/

For the 160 million consumers in the US with personalized diets, Kitchology is a social cooking platform that helps users rediscover the world of food by empowering them to customize and shop for recipes they will love. It is a free mobile app and website that supports meal planning and shopping online and/or in stores. For suppliers, Kitchology is a brand engagement and data analytics platform that allows manufacturers and retailers alike to actively engage with consumers and assist them in meal planning and shopping, avoid out of stock situations and get insight into behaviors. For wellness providers, Kitchology is a patient engagement platform and data analytics tool that allows wellness providers to actively engage with consumers through meal planning and shopping, and gain insight into patient behavior and outcome.

Kitchology

 

 

LinkedIn
Twitter
Facebook
YouTube
Instagram
Pinterest

worksource montgomery logoTo post job/internship opportunities, please email This email address is being protected from spambots. You need JavaScript enabled to view it. your request with the link/URL to your specific opportunity or to your page highlighting multiple opportunities.  Please also notify us once these position(s) are filled. Thank you.

 

3i Diagnostics, Inc. - Gaithersburg

Advanced BioScience Laboratories, Inc. (ABL) - Rockville

Aledade – Bethesda

Altimmune - Gaithersburg

Amarex Clinical Research – Germantown

American Gene Technologies – Rockville

Aphena – Easton

ARPA-H - Bethesda

AstraZeneca  – Frederick, Gaithersburg

ATCC – Gaithersburg, MD and Manassas, VA

Aurinia Pharmaceuticals – Rockville

Autolus – Gaithersburg, Rockville

b well - Baltimore

BioFactura - Frederick  

Cartesian Therapeutics  –  Gaithersburg

Catalent – Harmans

Champions Oncology, Inc. - Rockville

Children's National - DC

DrFirst – Rockville

Early Charm - Baltimore

Elixirgen Scientific - Baltimore

Ellume - Frederick

Emergent BioSolutions, Inc. - Baltimore, Gaithersburg, Rockville

EMMES Corp - Frederick, Rockville

Emocha Mobile Health, Inc.  – Baltimore

Frederick National Lab for Cancer Research - Frederick

GetWellNetwork, Inc. - Bethesda

GSK Global Vaccines US R&D Center - Rockville

GlycoMimetics, Inc. - Rockville

Henry Jackson Foundation – Bethesda and Silver Spring, MD

Horizon Therapeutics – Gaithersburg

Immunomic Therapeutics - Rockville

Institute for In Vitro Sciences - Gaithersburg

Intralytix - Baltimore and Columbia

Jecho Laboratories - Frederick

Johns Hopkins Technology Ventures – Baltimore

Johnson & Johnson – DC and Gaithersburg

KeyGene USA - Rockville

Kite Pharma (a Gilead Company) – Frederick, Gaithersburg

Landos Biopharma, Inc. – Reston

Leadiant Biosciences - Gaithersburg

Leidos Biomedical Research - Frederick

Lieber Institute for Brain Development – Baltimore

Lonza - Walkersville

Lupin Pharmaceuticals, Inc. - Baltimore

MacroGenics - Rockville

Maryland Department of Commerce - Baltimore

MaxCyte, Inc. – Gaithersburg

Maxim Biomedical – Rockville

Meso Scale Diagnostics – Rockville, Gaithersburg

Miltenyi Biotec - Gaithersburg

Mimetas - Gaithersburg

National Institutes of Health (NIH) - Bethesda

Netrias- Bethesda and Arlington

NexImmune - Gaithersburg

Nobile Life Sciences - Baltimore

Novavax, Inc. - Gaithersburg, Rockville

Novel MicroDevices - Baltimore

Noxilizer – Baltimore

Precigen – Germantown

Protenus - Baltimore

QIAGEN Sciences - Germantown, Frederick

Quality Biological - Gaithersburg, MD and D.C.  

REGENXBIO Inc. - Rockville

RoosterBio, Inc. – Frederick

Root3Labs - Randallstown

Sanaria, Inc. - Rockville

SeraCare - Gaithersburg

Senseonics - Germantown

Sirnaomics – Gaithersburg

Smith & Nephew - Columbia, MD

SoBran - Bethesda, Baltimore, Poolesville, Silver Spring

Sonavex Surgical, Inc. - Baltimore

Sterilex – Hunt Valley

Supernus Pharmaceuticals – Rockville

ThermoFisher Scientific - Baltimore, Bethesda, Frederick, DC

United Therapeutics - Silver Spring

University of Maryland Medical System - Maryland

U.S. Food and Drug Administration (FDA)

US Pharmacopeia - Rockville

Vaccitech - Maryland

Vanda Pharma - D.C.

Vheda Health - Columbia

WellDoc - Columbia

Westat - Rockville

tedco-impact-study-coverCOLUMBIA, Md. (Jan. 29, 2014) – A recent third-party economic development impact study conducted by Battelle Technology Partnership Practice (TPP), the world's largest non-profit research and development organization, has found that the Maryland Technology Development Corporation (TEDCO) currently supports more than $565.9 million in economic contributions and more than 2,835 jobs in the State of Maryland annually, earning $200.5 million in salaries with estimated State and local government revenues of $22.8 million. The study also determined the economic contribution of TEDCO programs is projected to grow to $910.3 million and support a total of 4,527 jobs by 2018. These jobs will earn $320.3 million in salaries with estimated State and local government revenues of $36.6 million.

Read the report here

mckinsey-company-logo

The US healthcare industry is undergoing a major transformation as healthcare reform encourages consumers to play a far more active decision-making role. Yet despite this traditionally business-to-business industry moving quickly to a business-to-consumer model, companies have been slow to join the digital movement. Unlike successful B2C companies in other industries—which offer mobile solutions, provide personalized product recommendations, and empower customer-service agents with a 360-degree view of the customer—most healthcare providers and payors are lagging, as are pharmaceutical companies and medical-device manufacturers

http://uverj.com/

ConVerjing major retailers and consumers by combining the power of best pricing with existing infrastructure and added levels of security to empower:

- Retailers to leverage the robust reporting and dynamic pricing capability of an ecommerce channel to potentially capture sales that may otherwise have been lost.

- Consumers to access major retailers on one easy-to-use site, getting the best possible price for all of their purchases.

Uverj

 

EIR logo


There is a large gap between disruptive technological innovations in Universities and federal labs and commercially relevant technologies that enter the market. One of the principal reasons for this gap is the absence of resources (entrepreneurs, knowledge base, capital, etc) to facilitate the movement of the technology along the commercialization path.

The Entrepreneur-in-Residence Program at BHI is aimed at ensuring that disruptive technologies receive all the resources that are required to transform the technology from a discovery into a commercially relevant product and eventually have a measurable impact on human health. The program has been created to support scientists, early stage start-ups and licensed technologies to provide them with access to these resources.

university-of-maryland-umd-logo

A University of Maryland medical student named Veena S. Katikineni is part of a pair of students that won a competition put on my Scientists Without Borders, in which they designed an innovative solution to deal with mental health issues.

Veena Katikineni (courtesy of her Twitter account, @VeenaSK125) Katikineni – along with Alejandra Leyton, a Bolivian-born health economist and master’s student at Tulane University, where she is studying public health – will split the $10,000 prize bestowed upon them. Their innovation is called “Mhealth for Mental Health,” which is an idea to use SMS text messaging services to provide fast, reliable, and relatively affordable information about mental health afflictions to communities around the world.

report-cover
On May 20, 2013, the White House Lab-To-Market Inter-Agency Summit was held in Washington, D.C. The Summit was organized by the White House Office of Science and Technology Policy and the National Institutes of Health's Heart, Lung, and Blood Institute. The purpose of the meeting was extraordinary: asking national experts outside of the federal agency system to recommend ways to increase the return-on-investment for the $140 billion annual taxpayer expenditure on federally-funded research and development.

nhlbi-logo-new.png

The purpose of the NHLBI SBIR Phase IIB Bridge Award is to facilitate and accelerate the capital-intensive steps that are required to transition SBIR Phase II projects to the commercialization stage by promoting partnerships between SBIR Phase II awardees and third-party investors and/or strategic partners. The Bridge Award encourages business relationships between applicant small business concerns and third-party investors/strategic partners who can provide substantial financing to help accelerate the commercialization of promising new products and technologies that were initiated with SBIR funding. In particular, applicants are expected to leverage their previous SBIR support, as well as the opportunity to compete for additional funding through the NHLBI Bridge Award program, to attract and negotiate third-party financing needed to advance a product or technology toward commercialization. The applicant’s ability to secure independent third-party investor funds that equal or exceed the total amount of the NHLBI funds being requested over the entire Bridge Award project period will help to validate the commercial potential that is essential for the SBIR projects solicited under the Bridge Award program. It is anticipated that many of the partnerships between small businesses and third-party investors will involve a considerable level of project due diligence by the private sector, thereby increasing the likelihood of commercial success for the funded projects. In light of these goals, the NHLBI strongly encourages applicants to establish business relationships with investors, strategic partners or both that have appropriate prior experience in commercializing emerging biomedical technologies.

2014-biomanufacturing-technology-summit

FRIDAY, JUNE 13, 2014 8:00 am

Emerging Strategies for the Production and Characterization of Biosimilars

The biomanufacturing industry faces an unprecedented challenge with the emergence of biosimilars.  The pathway to approval for biosimilars is a fluid process and several key aspects are still not determined.  The University of Maryland and the National Institute of Standards and Technology (NIST) will deliver a one-day symposium on the current trends of characterization and production of biosimilars.  On Friday, June 13, 2014 at 8:30 am join the thought-leaders, policy-makers, and creators of biosimilars as we present current trends, ideas, and predictions.

The BHI SBIR/STTR Federal Funding Assistance Program offers biohealth companies support in preparing applications for federal funding inclusive of SBIRs, STTRs, and other federal government awards. Companies submit their federal funding concepts and receive pre-proposal feedback to help troubleshoot and strengthen your application. Further support from professional consultants and service providers is available to assist in improving your application.

Read more...

nciia-open-logo

The NCIIA 19th annual conference--Open 2015--will be held March 20-21 in Washington, D.C. The conference will cover all aspects of tech entrepreneurship in higher education. Specific topics include program models, student perspectives, and entrepreneurship in low-resource settings. Call for Proposals now open: deadline 9/10.

About the Conference:

March 20-21, Washington, D.C.

NCIIA is dedicated to fostering an emerging generation of young inventors and entrepreneurs driven to improve life for people and the planet. Our Open conferences gather together engaged faculty and university students from across multiple disciplines to share stories, start new collaborations and learn best practices in technology entrepreneurship education.

bio-internation-convention

One of the under-appreciated features of the San Diego innovation ecosystem is the increasing significance of its proximity to one of North America’s most dynamic manufacturing hubs, Baja California, and in particular, Tijuana.

In 2006 my research team at UC San Diego published a bilingual report on the potential synergies between the innovation economy on the U.S. side of the border and the increasing manufacturing capabilities, engineering, and technical skills on the Mexican side. The cluster of manufacturing expertise includes companies in Tijuana that specialize in producing medical devices, pharmaceuticals, and electronics.

vheda-health-logo

Vheda Health, a digital health company that seeks to help people with chronic conditions, is one of a handful of healthcare startups that have received backing from a commercialization fund from Maryland’s Technology Development Corp. They were part of a list of 15 companies that received $1.5 million. It follows a funding allocation from earlier this year.

uk-trade-logo

To attend a NICE/UKTI Scientific Advice Seminar for developers of devices and diagnostics.

Learn how to prepare for an evaluation by NICE, the UK’s health technology assessment body.

The seminar will cover:

  • "Value" from the perspective of NICE
  • How value propositions link to the need for specific evidence
  • The types of evidence considered by NICE
  • The general principles of health technology assessment (HTA)
  • Advantages of doing business in the UK

Who should attend?

  • Developers of medical technologies, in particular SMEs
  • Investors in the field of medical technologies
  • Anyone new to the world of health technology assessment
  • Academics, scientists, or clinicians who want to know more about how NICE assesses the value of innovative products

The seminar program is funded by UKTI to allow you free event registration (standard event rate - $550)

mips-application-image

Maryland Industrial Partnerships (MIPS) Funding for Technology Product Development MIPS provides funding, matched by participating companies, for university research projects that help companies develop new technology products.

Benefits to Maryland Companies

  • Cost-effective research with world-class university faculty
  • Access to university students, state-of-the-art facilities, laboratories and equipment
  • Non-dilutive, non-debt funding for research
  • Opportunity to work directly with talented students—potential future hires
  • Rapid proposal evaluations—MIPS notifies award winners within 60 days of the proposal deadline

Benefits to Maryland Faculty

  • Research translates directly to new product development
  • Potential for published papers and improved university facilities
  • Students gain valuable experience working on commercial technologies

Visit www.mips.umd.edu or call 301.405.3891301.405.3891 for details.

APPLICATIONS ARE DUE BY OCTOBER 15, 2014!

johns-hopkins-new-logo

The left-brain right-brain divide is bunk. And a Baltimore graduate program is celebrating that.

“We have people who have worked in the military, nonprofits, startups, started their own company, worked for huge corporations,” said Julie Buisson, a graduate assistant with the Design Leadership MBA/MA program from Johns Hopkins University’s Carey Business School and the Maryland Institute College of Art.

converge-medcity-2014-logo.png

Healthcare startups, and all startups for that matter, need investors and funding to stay alive. For this reason, MedCity is pleased to announce that investor Andrew Jay, MD, will be speaking at CONVERGE. Dr. Jay is the head of the medical solutions fund at HealthCare Fund at Siemens Venture Capital, which invests in companies focusing on imaging, diagnostics and health IT.

Jay will be speaking on the second day of MedCity CONVERGE at 9:20 a.m. The third annual CONVERGE is July 15-16 in Philadelphia.